Documente Academic
Documente Profesional
Documente Cultură
Source: Adapted from the World Federation of Exchanges 2008 Report (see
http://www.world-exchanges.org).
EXHIBIT 8-3 REAL RETURNS ON GLOBAL EQUITY
SECURITIES, BONDS, AND BILLS DURING 1900-2008
Source: Adapted from the 2008 Australian Share Ownership Study conducted by
the Australian Securities Exchange (see http://www.asx.com.au). For Australia
and the United States, the data pertain to direct and indirect ownership in equity
markets; for other countries, the data pertain to direct ownership in shares and
share funds. Data not available in specific years are shown as N/A.
COMMON SHAREHOLDERS
Statutory
voting
Vote by proxy
Voting Cumulative
rights voting
Share
classes
EMBEDDED OPTIONS
Callable
common
shares Putable common
shares
PREFERENCE SHARES (PREFERRED STOCK)
DIVIDENDS ON PREFERENCE SHARES
POSSIBLE ADVANTAGES OF CONVERTIBLE
PREFERENCE SHARES
PRIVATE EQUITY SECURITIES
INVESTING IN NONDOMESTIC EQUITY
SECURITIES
EXHIBIT 8-16 SUMMARY OF THE MAIN FEATURES OF
AMERICAN DEPOSITORY RECEIPTS
Higher risk:
Callable
Nonputable
Noncumulative
Lower risk:
Noncallable
Putable
Cumulative
WHY ISSUE EQUITY?
GOALS FOR MANAGING EQUITY
Manage investors
expectations
ACCOUNTING RETURN ON EQUITY (ROE)
Financial Year Ending
31 Dec 2008 31 Dec 2007 31 Dec 2006
Pfizer
Net income $8,104,000 $8,144,000 $19,337,000
Total stockholders equity $57,556,000 $65,010,000 $71,358,000
NIt
ROE t
BVE t BVE t 1 / 2
$8,144,000
ROE 2007 11.9%
($65,010,000 $71,358,000) / 2
$8,104,000
ROE 2008 13.2%
($57,556,000 $65,010,000) / 2
MARKET VALUE, BOOK VALUE, AND
PRICE-TO-BOOK RATIO
Price-to-book ratio = Market price per share/Book value of equity per share
Price-to-book ratio = US$16.97/US$8.53 = 1.99
THE COST OF EQUITY
INVESTORS REQUIRED RATE OF
RETURN